Biomedicine & Pharmacotherapy (Oct 2024)

Histone deacetylases and their inhibitors in inflammatory diseases

  • Sen-Yu Zhang,
  • Li-Ying Zhang,
  • Ri Wen,
  • Ni Yang,
  • Tie-Ning Zhang

Journal volume & issue
Vol. 179
p. 117295

Abstract

Read online

Despite considerable research efforts, inflammatory diseases remain a heavy burden on human health, causing significant economic losses annually. Histone deacetylases (HDACs) play a significant role in regulating inflammation (via histone and non-histone protein deacetylation) and chromatin structure and gene expression regulation. Herein, we present a detailed description of the different HDACs and their functions and analyze the role of HDACs in inflammatory diseases, including pro-inflammatory cytokine production reduction, immune cell function modulation, and anti-inflammatory cell activity enhancement. Although HDAC inhibitors have shown broad inflammatory disease treatment potentials, their clinical applicability remains limited because of their non-specific effects, adverse effects, and drug resistance. With further research and insight, these inhibitors are expected to become important tools for the treatment of a wide range of inflammatory diseases. This review aims to explore the mechanisms and application prospects of HDACs and their inhibitors in multiple inflammatory diseases.

Keywords